Clinical Trial Update: A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase III clinical trial investigating napabucasin (GB201) plus FOLFIRI in adults with previously treated metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• napabucasin (GB201) (napabucasin)

Snippet

Sponsor: 1Globe Health Institute LLC | Conditions: Previously Treated Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN